Author

Iñaki Etxeberría

Memorial Sloan Kettering Cancer CenterORCID 0000-0003-2713-0836Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Christopher Austin KlebanoffiD· 2 shared Aaron A. DiaziD· 1 shared Abhilash BarpandaiD· 1 shared Aidan Du· 1 shared Akane YamamichiiD· 1 shared Anthony F. DaniyaniD· 1 shared Arun P. WiitaiD· 1 shared Atsuro SaijoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Christopher Austin KlebanoffORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyNature CancerPeer-reviewedJul 22, 2025

CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit

Fei Yi, Tal Cohen, Natalie Zimmerman…·Christopher Austin Klebanoff

This study identifies FASLG expression patterns and shows that FAS-L/FAS auto-regulation governs CAR-T and CAR-NK cell persistence, enhancing antitumor efficacy when FAS is inhibited.

55 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyNaturePeer-reviewedFeb 19, 2025

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens

Darwin W. Kwok, Nicholas O. Stevers, Iñaki Etxeberría…·Hideho Okada

The paper identifies tumor-wide splicing aberrations that generate public neoantigens, enabling T-cell-based immunotherapies targeting intratumoral heterogeneity.

112 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky